Sponsor Pipeline

Nanjing University School of Medicine Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07340463 The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in… Systemic Lupus Erythematosus (SLE) Recruiting
Phase 1
NCT06285279 The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases Lupus Nephritis Recruiting
Not specified
NCT06376214 Daratumumab for Patients With Light Chain Amyloidosis Light Chain (AL) Amyloidosis Recruiting
NCT04210791 Autologous Stem Cell Transplantation for Patients With AL Amyloidosis AL Amyloidosis Enrolling by Invitation
NCT06226896 Effects of Dapagliflozin on Progression of Alport Syndrome Alport Syndrome Active, Not Recruiting
Disease Areas
Amyloidosis (2) Lupus (SLE) (2)
Get alerts when Nanjing University School of Medicine's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free